Two sentences about launch Lorem ipsum dolor sit amet, consectetur adipisicing elit. Eveniet autem beatae enim fuga laudantium voluptatibus, a officiis minus necessitatibus.
To provide superior quality healthcare services that: PATIENTS recommend to family and friends, PHYSICIANS prefer for their patients, PURCHASERS select for their clients, EMPLOYEES are proud of, and INVESTORS seek for long-term returns.
To provide superior quality healthcare services that: PATIENTS recommend to family and friends, PHYSICIANS prefer for their patients, PURCHASERS select for their clients, EMPLOYEES are proud of, and INVESTORS seek for long-term returns.
Indications: Risperidone is used for treatment of Schizophrenia, Bipolar mania and irritability associated with Autistic Disorder.
Indications: Sertraline is used for Major depressive disorder, Panic disorder, Premenstrual dysphoric disorder, Posttraumatic stress disorder, Social anxiety disorder and Obsessive compulsive disorder.
Indications: Olanzapine is used for treatment of Schizophrenia and Bipolar mania.
Indications: Citalopram is used for the treatment of major depression, social phobia, panic disorder and obsessive-compulsive disorder.
Indications: Paroxetine is used for the treatment of Depression, Obsessive-compulsive disorder, Panic disorder, Social phobia, Generalized anxiety disorder, Posttraumatic stress disorder and Premenstrual dysphoric disorder.
General Manager
Dr. Ehab has long experience in Pharmaceutical market, between Sales, Marketing & Business Development in Egypt & GCC with big multinationals such as Abbott & Eli Lilly. Dr. Ehab holds a Masters degree in Business Administration from Eslsca business school.
Scientific Office Manager
Dr. Nashaat comes in with a very strong experience in Sales; after spending 33 years between Sandoz and Novartis, through which he has gone through several roles in Sales from Medical Rep to NSM for Diabetes line with Novartis. Dr. Nashaat is very well known for his exceptional leadership skills and commitment to business results.
New innovations in the field of pharma.
Fair competition in favor of the Egyptian patient.
To enrich the Egyptian market with new classes.
To Support HCPs with new options in managing chronic and acute diseases.